To test this hypothesis, we performed complementation experiments in SH-SY5Y cells depleted for PINK1 (shPINK1), by over-expressing PINK1 wild-type protein (WT) or two PD-associated pathogenic mutants characterized by a different capacity to bind Beclin1 [21]. This evidence concerns the gene BECN1 and Parkinson disease.